Nemes Rush Group »

Bioline Rx shares owned by Nemes Rush Group

Quarter-by-quarter ownership of Bioline Rx (BLRX) shares owned by Nemes Rush Group from 13F filings

Historical chart of Nemes Rush Group investment in Bioline Rx

Tip: Access up to 7 years of quarterly data

All positions including Bioline Rx held by Nemes Rush Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioline Rx by Nemes Rush Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $945 250 3.78
2025-06-30 $1.1k 250 4.57
2025-03-31 $888 300 2.96

More positions owned by Nemes Rush Group

Broadcom (AVGO)
Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
JPMorgan Chase & Co. (JPM)
Alphabet Incorporated Cap Stk Class A Cap Stk Cl A (GOOGL)
Meta Platforms Incorporated Class A Cl A (META)
Home Depot (HD)
Motorola Solutions Incorporated Com New (MSI)
Wal-Mart Stores (WMT)
Lam Research Corporation Com New (LRCX)
D.R. Horton (DHI)
Qualcomm (QCOM)
Eaton Corporation SHS (ETN)
Cisco Systems (CSCO)

View all positions for Nemes Rush Group

Top funds holding Bioline Rx

Susquehanna International
Citadel Advisors
UBS Group
Rhumbline Advisers
Wells Fargo & Company
Nemes Rush Group
Goss Wealth Management
Simplex Trading
Tower Research Capital
Rockefeller Capital Management
SBI Securities
Danske Bank A/s
Advisor Group Holdings

View all funds holding Bioline Rx